The Rise of Compounded Medications
The Case for Compounded Medications in Modern Formularies
A Shift in How Medications Are Designed and Delivered
For years, compounded medications were viewed as niche solutions, reserved for edge cases when commercially available drugs could not meet a patient’s needs. Today, that perception is changing. As healthcare moves toward more individualized care, the ability to tailor medications is becoming less of an exception and more of an expectation.
Compounding allows licensed pharmacists to prepare medications that are customized in strength, dosage form, or ingredient composition. This can support patients with allergies, unique dosing requirements, or specific therapeutic goals that standard options do not fully address. What was once considered specialized is not aligning more closely with how care is evolving across the broader system.
From Niche to Necessary
Demand for certain therapies, particularly in metabolic health, brought new visibility to compounding. As access challenges and supply constraints surfaced, compounded options helped fill critical gaps.
That shift accelerated adoption across the healthcare ecosystem:
- Providers began incorporating compounded options into treatment plans
- Employers explored new ways to expand access for their populations
- Digital health platforms integrated compounding into their care models
Compounding is no longer operating on the margins. It is increasingly considered alongside traditional medications as part of a more flexible formulary strategy.
What This Means for Members
For members, the inclusion of compounded medications can expand access in meaningful ways. It introduces options that better align with individual physiology, preferences, and tolerability.
This can support:
- More personalized dosing aligned to clinical data
- Improved adherence through better-suited formulations
- Access to therapies when commercial options are unavailable or delayed
As care models incorporate lab work, biomarkers, and ongoing health data, formularies that reflect this shift are better positioned to support a wider range of needs.
How Employers and Digital Health Are Responding
Employers and digital health organizations are beginning to take a closer look at how compounded medications fit into their broader pharmacy strategies. The focus is not only on access, but also on creating a more adaptable system that can respond to changing patient needs without unnecessary friction.
Formularies are being revisited with greater flexibility in mind, allowing for the inclusion of compounded therapies where appropriate. Digital health platforms, in particular, are well-positioned to support this shift, as they can connect prescribing, fulfillment, and patient engagement in a more coordinated way.
Looking Ahead: The Role of Technology in Compounding
As compounding continues to evolve, technology will play a larger role in how these medications are developed and delivered. Data-informed approaches are already shaping therapies in areas such as hormone health, dermatology, and oncology, where patient variability is especially high.
Emerging tools, including AI-driven insights, have the potential to further refine how formulations are tailored. This does not replace clinical judgement, but it enhances the ability to align treatments more closely with individual patient profiles.
Compounded medications are no longer a workaround. They are becoming part of a more thoughtful and responsive approach to pharmacy care, one that reflects where healthcare is heading rather than where it has been.